Cadmus Rich

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Julie Feder, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Cadmus Rich:

Company Role Class Num Shares Value Price $ Report Date Ownership
Aura Biosciences, Inc. Chief Medical Officer, Head of R&D Common Stock 58,703 $448,579 $7.64 19 Jan 2023 Direct
Aura Biosciences, Inc. Chief Medical Officer, Head of R&D Stock Option (Right to Buy) 52,500 19 Jan 2023 Direct

Insider Reports Filed by Cadmus Rich

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AURA Aura Biosciences, Inc. 19 Jan 2023 2 $0 4 Chief Medical Officer, Head of R&D 23 Jan 2023, 17:34
AURA Aura Biosciences, Inc. 31 Oct 2022 1 -$20,813 4 Chief Medical Officer, Head of R&D 02 Nov 2022, 20:38
AURA Aura Biosciences, Inc. 28 Oct 2021 2 $0 4 Chief Medical Officer Head of R&D 29 Oct 2021, 19:32
AURA Aura Biosciences, Inc. 28 Oct 2021 0 $0 3 Chief Medical Officer Head of R&D 28 Oct 2021, 20:30